[Prenatal diagnosis and genetic analysis of 17 fetuses with skeletal dysplasia]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Nov 10;37(11):1217-1221. doi: 10.3760/cma.j.cn511374-20191216-00639.
[Article in Chinese]

Abstract

Objective: To explore strategies of prenatal genetic testing for fetuses featuring abnormal skeletal development.

Methods: Clinical data of 17 fetuses with skeletal dysplasia was collected. The results of genetic testing and outcome of pregnancy were analyzed.

Results: For 12 fetuses, the femur-to-foot length ratio was less than 0.9. Thirteen fetuses had a positive finding by genetic testing. One fetus was diagnosed with chromosomal aneuploidy, three were diagnosed with microdeletion/microduplications, and nine were diagnosed with hereditary bone diseases due to pathological variants of FGFR3, COL1A2, GPX4 or ALPL genes.

Conclusion: For fetuses with skeletal dysplasia characterized by short femur, in addition to chromosomal karyotyping and microarray analysis, sequencing of FGFR3 and other bone disease-related genes can improve the diagnostic rate.

MeSH terms

  • Bone Diseases, Developmental / diagnosis*
  • Bone Diseases, Developmental / genetics*
  • Female
  • Fetus / diagnostic imaging
  • Genetic Testing
  • Humans
  • Karyotyping
  • Pregnancy
  • Prenatal Diagnosis*
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Ultrasonography, Prenatal*

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3